Published in J Biol Chem on November 29, 2011
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR (1994) 22.42
TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts. J Biomol NMR (2009) 16.09
Generating a prion with bacterially expressed recombinant prion protein. Science (2010) 6.26
NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A (2000) 4.80
A transmembrane form of the prion protein in neurodegenerative disease. Science (1998) 3.76
Structure determination of membrane proteins by NMR spectroscopy. Chem Rev (2004) 3.25
Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci (2010) 2.25
Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem (1999) 1.83
Site-directed parallel spin-labeling and paramagnetic relaxation enhancement in structure determination of membrane proteins by solution NMR spectroscopy. J Am Chem Soc (2006) 1.73
Prion diseases and their biochemical mechanisms. Biochemistry (2009) 1.65
Phosphate-mediated arginine insertion into lipid membranes and pore formation by a cationic membrane peptide from solid-state NMR. J Am Chem Soc (2007) 1.63
Three-dimensional structures of prion proteins. Adv Protein Chem (2001) 1.46
Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions. J Mol Biol (2006) 1.43
Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry (1989) 1.36
Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves. J Am Chem Soc (2007) 1.22
NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126. Proc Natl Acad Sci U S A (2003) 1.22
Most pathogenic mutations do not alter the membrane topology of the prion protein. J Biol Chem (2000) 1.19
Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform. J Biol Chem (2003) 1.12
N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro. J Biol Chem (2001) 1.12
Membrane-bound dynamic structure of an arginine-rich cell-penetrating peptide, the protein transduction domain of HIV TAT, from solid-state NMR. Biochemistry (2010) 1.09
Implicit solvent simulations of DPC micelle formation. J Phys Chem B (2005) 1.09
Prion protein misfolding and disease. Curr Opin Struct Biol (2009) 1.06
Making membrane proteins for structures: a trillion tiny tweaks. Nat Methods (2010) 0.99
Determinants of carboxyl-terminal domain translocation during prion protein biogenesis. J Biol Chem (1994) 0.98
Prion protein biosynthesis and its emerging role in neurodegeneration. Trends Biochem Sci (2009) 0.97
Conformational dimorphism and transmembrane orientation of prion protein residues 110-136 in bicelles. Biochemistry (2001) 0.94
Preparation of insoluble transmembrane peptides: glycophorin-A, prion (110-137), and FGFR (368-397). Anal Biochem (1999) 0.91
Prion protein-detergent micelle interactions studied by NMR in solution. J Biol Chem (2009) 0.89
Influence of phosphocholine alkyl chain length on peptide-micelle interactions and micellar size and shape. J Phys Chem B (2010) 0.87
Functional implications of multistage copper binding to the prion protein. Proc Natl Acad Sci U S A (2009) 0.86
Effective critical micellar concentration of a zwitterionic detergent: a fluorimetric study on n-dodecyl phosphocholine. J Fluoresc (2009) 0.83
Conformational properties of peptide fragments homologous to the 106-114 and 106-126 residues of the human prion protein: a CD and NMR spectroscopic study. Org Biomol Chem (2004) 0.81
Assessment of the three-dimensional structure of recombinant protein therapeutics by NMR fingerprinting: demonstration on recombinant human granulocyte macrophage-colony stimulation factor. Anal Chem (2008) 0.95
Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524). J Med Chem (2007) 0.95
Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences. Vaccine (2010) 0.92
Steady-state kinetics and inhibition of anaerobically purified human homogentisate 1,2-dioxygenase. Biochem J (2005) 0.82
Assessment of the effects of pH, formulation and deformulation on the conformation of interferon alpha-2 by NMR. J Pharm Sci (2010) 0.81
A single N-acetylgalactosamine residue at threonine 106 modifies the dynamics and structure of interferon α2a around the glycosylation site. J Biol Chem (2012) 0.80
Peptides derived from two dynamically disordered proteins self-assemble into amyloid-like fibrils. J Am Chem Soc (2003) 0.78
NMR assignment of human granulocyte-macrophage colony-stimulating factor. Biomol NMR Assign (2007) 0.76
In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites. Bioorg Med Chem Lett (2006) 0.75
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile. Bioorg Med Chem Lett (2002) 0.75
Discovery, biosynthesis, and structure elucidation of new metabolites of norandrostenedione using in vitro systems. Steroids (2005) 0.75
NMR assignment of the N-terminal TRAF-like RING zinc finger domain of human FLN29. Biomol NMR Assign (2007) 0.75
Backbone and side chain 1H, 13C and 15N resonance assignments of the catalytic domain of diphtheria toxin. Biomol NMR Assign (2011) 0.75